VeraDermics has officially announced the Phase 2/3 results of its drug VDPHL01, developed for the treatment of male pattern hair loss.
At the end of 6 months, an average of 30.3 to 33.0 new hairs per square centimeter were observed in those using the drug.
[Before & After photos]
This treatment is notable for its single-dose daily and non-hormonal nature.
The difference between the drug and the placebo is approximately 23–26 hairs/cm².
0 Comments